How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
1. Recursion Pharmaceuticals uses NVIDIA's AI to accelerate drug discovery. 2. Big Pharma struggles with innovation while AI companies gain investor confidence. 3. Tempus AI shows resilience despite market pullback, indicating strong growth prospects. 4. Palantir's stock rise signals increasing excitement around AI in healthcare. 5. AI-driven firms are disrupting traditional drug development processes significantly.